Literature DB >> 7633185

DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations.

K Goto1, J H Lee, C Matsuda, K Hirabayashi, T Kojo, A Nakamura, Y Mitsunaga, T Furukawa, K Sahashi, K Arahata.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscular disorder in which the disease locus has been mapped to chromosome 4q35-qter. In most patients, the DNA rearrangements associated with FSHD have been found in the EcoRI fragment detected by the p13E-11 probe, and deletions of the 3.2 kb repeat units within the fragment are thought to cause the disease. To examine FSHD-associated DNA rearrangements in the Japanese population, we performed Southern blot analysis of the genomic DNA, using the p13E-11 and pFR-1 probes, in 158 Japanese individuals, including 38 FSHD patients from 19 families. We found that all but one (a possible affected recombinant) of the Japanese FSHD patients (97.4%) had specific smaller (< 28 kb) EcoRI fragments which cosegregated with the disease; this included four patients who had severe inflammatory changes in the muscle and eight patients with de novo DNA rearrangements. We found no FSHD patient who had a fragment larger than 28 kb. By contrast, only two of 35 Japanese controls (5.7%) had EcoRI fragments smaller than 28 kb. Our patients showed anticipation, i.e. decreased size of the EcoRI fragment in parallel with earlier onset of the disease (r = 0.531, P = 0.003, with younger age at onset in children (17.8 +/- 7.0) than their affected parents (31.5 +/- 14.8) (P = 0.019). However, since each family had a specific small EcoRI fragment associated with the disease, the differing clinical severity within a family cannot be explained by the size of the fragment alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633185     DOI: 10.1016/0960-8966(94)00055-e

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.

Authors:  Sabrina Sacconi; Richard J L F Lemmers; Judit Balog; Patrick J van der Vliet; Pauline Lahaut; Merlijn P van Nieuwenhuizen; Kirsten R Straasheijm; Rashmie D Debipersad; Marianne Vos-Versteeg; Leonardo Salviati; Alberto Casarin; Elena Pegoraro; Rabi Tawil; Egbert Bakker; Stephen J Tapscott; Claude Desnuelle; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2013-09-26       Impact factor: 11.025

Review 2.  Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Antioxid Redox Signal       Date:  2014-12-04       Impact factor: 8.401

Review 3.  Genetic and epigenetic contributors to FSHD.

Authors:  Lucia Daxinger; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Curr Opin Genet Dev       Date:  2015-09-07       Impact factor: 5.578

Review 4.  Deciphering transcription dysregulation in FSH muscular dystrophy.

Authors:  Melanie Ehrlich; Michelle Lacey
Journal:  J Hum Genet       Date:  2012-06-21       Impact factor: 3.172

Review 5.  Genotype-phenotype correlations in FSHD.

Authors:  Nikolay Zernov; Mikhail Skoblov
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

Review 6.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

7.  Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Authors:  Rabi Tawil; John T Kissel; Chad Heatwole; Shree Pandya; Gary Gronseth; Michael Benatar
Journal:  Neurology       Date:  2015-07-28       Impact factor: 9.910

8.  Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.

Authors:  Hiroaki Mitsuhashi; Satomi Mitsuhashi; Taylor Lynn-Jones; Genri Kawahara; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2012-10-29       Impact factor: 6.150

9.  The Facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure.

Authors:  Monica Rossi; Enzo Ricci; Luca Colantoni; Giuliana Galluzzi; Roberto Frusciante; Pietro A Tonali; Luciano Felicetti
Journal:  BMC Med Genet       Date:  2007-03-02       Impact factor: 2.103

10.  Chromosome 4q;10q translocations; comparison with different ethnic populations and FSHD patients.

Authors:  Tsuyoshi Matsumura; Kanako Goto; Gaku Yamanaka; Je Hyeon Lee; Cheng Zhang; Yukiko K Hayashi; Kiichi Arahata
Journal:  BMC Neurol       Date:  2002-08-20       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.